BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed

BBOT Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
--134.04-74.28-0.04-0
Depreciation & Amortization
-0.610.21--
Stock-Based Compensation
-5.874.43--
Other Adjustments
-6.988.460.030
Changes in Other Operating Activities
-9.926.696.160.02-
Operating Cash Flow
-130.21-113.89-55.0300
Capital Expenditures
--0.61-0.05--
Purchases of Investments
--83.93-154.43--
Proceeds from Sale of Investments
-157.8631.54--
Other Investing Activities
--2.41--
Investing Cash Flow
-227.4573.33-120.53--
Issuance of Common Stock
-373.51.11--
Net Common Stock Issued (Repurchased)
-373.51.11--
Issuance of Preferred Stock
-22.22205.18--
Net Preferred Stock Issued (Repurchased)
-22.22205.18--
Other Financing Activities
--12.32---
Financing Cash Flow
384.1383.4206.29--
Net Cash Flow
-0.52342.8430.7300
Free Cash Flow
-130.21-114.5-55.0800
Free Cash Flow Per Share
-3.64-3.68-1.77--
Levered Free Cash Flow
-9-127.35-67.96-0.03-0
Unlevered Free Cash Flow
-149.81-139.13-74.54-0.03-0